Innovative Healthcare Platform Secures Transformative Investment

Irwin Mitchell’s Corporate team has advised Manchester-based SiSU Health, a platform focused on prevention, early intervention and addressing health inequalities on its £1.25m fundraising.

The proceeds will be used to expand its team and accelerate the reach of its technology across the UK and Europe and working with the Department of Business & Trade to source a larger premises.   

SiSU, a corporate spinout led by CEO Samantha Fay, provides data sets to local authorities, the NHS, and employers. SiSU Health facilitates wider health and economic benefits by detecting risk factors like high blood pressure and obesity, encouraging healthier lifestyle changes.

The investment has been secured from the GMC Life Sciences Fund By Praetura, which comprises Bruntwood SciTech, Greater Manchester Combined Authority and Enterprise Cheshire and Warrington. Investment has also come from NPIF II – Praetura Equity Finance, which is also managed by Praetura as part of The Northern Powerhouse Investment Fund II.

Adam Kaucher, Corporate partner at Irwin Mitchell, along with Kieran Shields, supported SiSU on the deal. 

Expert Opinion

"We are delighted to have supported SiSU Health in this important fundraising journey. This investment will enable SiSU to scale their operations and deliver substantial health and economic benefits across the UK and Europe. We are proud to have played a role in helping them achieve their ambitious vision." Adam Kaucher, Corporate partner at Irwin Mitchell.

Samantha Fay, CEO at SiSU Health, said: “We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers.”  

Sim Singh-Landa, head of the GMC Life Sciences Fund By Praetura, said: “SiSU Health is bringing health into the modern age by helping individuals to take a health test at a time that’s convenient to them without judgement and the costs that can be associated with health checks. They are critically providing connected collaboration between the corporate world and public health systems, encouraging self-care and health awareness for individuals with supported follow-up and interventions, which has significant benefits for the NHS and public health. This latest co-investment between the GMC Life Sciences Fund By Praetura and NPIF II also shows the power of two well-established regional funders working together to help propel great companies in the region.”